Amplifying the size and diversity of participant pools in clinical trials enhances statistical power and increases the generalizability of study findings.
Amit Vasanji, PhD, and Brett A. Hoover
Advertisement
Articles by Amit Vasanji, PhD, and Brett A. Hoover
Advertisement
Latest Updated Articles
Five Critical Qualities for Identifying a Partner to Globally Scale Ophthalmology Clinical TrialsPublished: March 22nd 2024 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
When AI Learns to Speak Every Language: An eCOA Migration Study
2
Upskilling Community Cancer Centers: A Training Pilot Hints at Promising Ways to Boost Oncology Clinical Research
3
ACT Brief: AI-Enabled COA Migration, Expanding Trial Footprints into Routine Care, and New FDA Approval in Myasthenia Gravis
4
FDA Outlines New Superiority Standard for Future CAR-T Approvals
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
